Heart failure symptoms have been reversed in patients with a new pacemaker that changes how the heart is fuelled.
Clinical Trials Arena on MSN
CVRx’s stock up as heart failure device to be trialled in expanded patient group
The device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.
Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...
The new report examined numbers from 2023, the latest year for which data were available. Deaths from cardiovascular diseases totaled 916,000, including about 680,000 deaths from heart disease and 180 ...
Scientists have uncovered why people with chronic kidney disease so often die from heart problems: damaged kidneys release ...
A major study links prolonged melatonin use to a significantly higher risk of heart failure, hospitalisation, and death ...
Cassandra King was thrilled to be pregnant after years of fertility struggles and multiple miscarriages. Then a sudden ...
Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is ...
13don MSN
This Prevalent Condition Reshapes The Human Heart (And Not In A Good Way)—Here’s How To Prevent It
Doctors break it all down.
Using nearly a decade of data (2015–2023) from 800+ U.S. hospitals and more than 700,000 patients overall, Northwestern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results